医学
氨基糖苷
肾毒性
内科学
胃肠病学
抗生素
药理学
庆大霉素
梅德林
肿瘤科
作者
Courtney Munro,Elena K. Schneider‐Futschik,Catherine Quinlan,Sarath Ranganathan
标识
DOI:10.1016/j.clinthera.2026.09.010
摘要
PURPOSE: People with CF (pwCF) have historically been treated often and with prolonged intravenous aminoglycosides courses, which are known to cause nephrotoxicity. Despite this, kidney impairment in pwCF is often under-recognised, in part due to limitations of traditional serum markers such as creatinine. This study aimed to explore the utility of urinary biomarkers in detecting aminoglycoside-induced nephrotoxicity in pwCF, and to compare biomarker profiles with healthy children. METHODS: In the PIANO-CF study we evaluated renal biomarkers in three groups: (A) children with cystic fibrosis aged 0 to less than 7 years receiving intravenous aminoglycoside, (B) clinically stable children with cystic fibrosis not receiving intravenous aminoglycoside, and (C) age-matched healthy controls (HC). A total of 29 pwCF were prospectively recruited during hospital admissions for intravenous aminoglycoside, and 65 pwCF provided urine samples from a biobank. We also recruited 269 healthy children. To compare biomarkers between groups, we used a generalised estimating equation. FINDINGS: Children with cystic fibrosis had significantly lower urinary kidney injury molecule-1 (uKIM-1; 126.7 pg/mL lower) and urinary neutrophil gelatinase-associated lipocalin (uNGAL; 7.07 ng/mL lower) than healthy controls (HC). For pwCF receiving intravenous aminoglycosides, uKIM-1 and uNGAL increased 1.9-fold and 2.05-fold respectively, despite stable serum creatinine (sCr); however, only three children (10%) met pRIFLE criteria for acute kidney injury (AKI), precluding formal assessment of biomarker sensitivity or specificity for AKI detection. No correlation was found between serum and urinary biomarker levels. No association was found between prior aminoglycoside exposure and uKIM-1 levels. IMPLICATIONS: These exploratory findings reveal a distinct urinary biomarker signature in children with cystic fibrosis compared to healthy controls, and demonstrate that uKIM-1 and uNGAL increase with intravenous aminoglycoside exposure despite stable sCr. These observations support the need to establish CF-specific biomarker reference ranges and to design adequately powered prospective studies to formally assess the utility of these biomarkers in detecting aminoglycoside-induced nephrotoxicity.
科研通智能强力驱动
Strongly Powered by AbleSci AI